TWD
TXG icon

True Wealth Design’s 10x Genomics TXG Stock Holding History

True Wealth Design’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168K Sell
4,385
-427
-9% -$11.2K 0.04% 140
2026
Q1 		$102K Buy
4,812
+203
+4% +$4.06K 0.03% 209
2025
Q4 		$75.2K Buy
4,609
+75
+2% +$1.13K 0.02% 234
2025
Q3 		$53K Buy
4,534
+948
+26% +$12.4K 0.02% 303
2025
Q2 		$41.5K Buy
3,586
+3,369
+1,553% +$30.7K 0.01% 233
2025
Q1 		$1.9K Sell
217
-530
-71% -$6.68K ﹤0.01% 1029
2024
Q4 		$10.7K Buy
747
+672
+896% +$10.6K ﹤0.01% 411
2024
Q3 		$1.69K Buy
+75
New +$1.55K ﹤0.01% 837

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

True Wealth Design's TXG Position: Q2 2026 in Review

True Wealth Design reduced its 10x Genomics (TXG) stake by 8.9% in Q2 2026, selling an estimated $11.2K and leaving 4,385 shares worth $168K. The position accounts for 0.04% of the portfolio, ranked #140.

True Wealth Design first reported a position in TXG in Q3 2024 and has held it in 8 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • True Wealth Design held 4,385 shares of 10x Genomics worth $168K as of Q2 2026.
  • True Wealth Design sold 427 10x Genomics shares in Q2 2026, an estimated $11.2K.
  • 10x Genomics made up 0.04% of True Wealth Design's portfolio in Q2 2026, its #140 holding.
  • True Wealth Design first reported a position in 10x Genomics in Q3 2024 and has held it in 8 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.